Quince Therapeutics, Inc. (QNCX)
NASDAQ · Manufacturing · Biological products, (no diagnostic substances)
$31.00+$1.00 (+3.33%) on the dayAs of the close; data may be delayed.
QNCX price, last 12 months
Key stats
- Previous close
- $30.00
- Open
- $30.40
- Day range
- $29.98 – $31.00
- 52-week range
- $15.10 – $909.98
- Volume
- 6.5K
- Avg volume (20 days)
- 20.1K
- Market cap
- $31.5M
Performance
1W+5.2%
1M−1.0%
3M+64.3%
6M+64.7%
YTD−95.4%
1Y−90.4%
vs S&P 500, 1Y−107.2 pts
Technicals and fundamentals
About Quince Therapeutics, Inc.
Quince Therapeutics Inc is a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases. Its proprietary AIDE technology is an inventive drug/device combination platform that uses an automated process to encapsulate a drug into a patient's own red blood cells. Its Phase 3 asset, eDSP, leverages the AIDE technology to encapsulate DSP into a patient's own red blood cells, and is targeted to treat a rare pediatric neurodegenerative disease, A-T.
- Sector
- Manufacturing
- Industry
- Biological products, (no diagnostic substances)
- Listed on
- NASDAQ
- Market cap
- $31.5M